KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $6.3 billion.

  • Oscar Health's Liabilities and Shareholders Equity rose 3067.69% to $6.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $24.3 billion, marking a year-over-year increase of 2960.59%. This contributed to the annual value of $6.3 billion for FY2025, which is 3067.69% up from last year.
  • Per Oscar Health's latest filing, its Liabilities and Shareholders Equity stood at $6.3 billion for Q4 2025, which was up 3067.69% from $5.7 billion recorded in Q3 2025.
  • Oscar Health's 5-year Liabilities and Shareholders Equity high stood at $6.4 billion for Q2 2025, and its period low was $3.2 billion during Q3 2021.
  • In the last 5 years, Oscar Health's Liabilities and Shareholders Equity had a median value of $4.5 billion in 2023 and averaged $4.5 billion.
  • Per our database at Business Quant, Oscar Health's Liabilities and Shareholders Equity soared by 4619.26% in 2021 and then tumbled by 2226.18% in 2023.
  • Quarter analysis of 5 years shows Oscar Health's Liabilities and Shareholders Equity stood at $3.3 billion in 2021, then soared by 36.28% to $4.5 billion in 2022, then fell by 20.44% to $3.6 billion in 2023, then soared by 34.4% to $4.8 billion in 2024, then skyrocketed by 30.68% to $6.3 billion in 2025.
  • Its Liabilities and Shareholders Equity was $6.3 billion in Q4 2025, compared to $5.7 billion in Q3 2025 and $6.4 billion in Q2 2025.